68Ga-PSMA-HBED-CC PET/CT 显示转移性分化型甲状腺癌前列腺特异性膜抗原表达的初步证据
PSMA PET检出30/32个病灶(93.75%),其中21个(70%)位于骨骼;2例TENIS患者中PSMA PET均定位到病灶。作者认为68Ga-PSMA-HBED-CC PET/CT是潜在有用的影像手段,或有助于识别可从PSMA靶向放射性核素治疗中获益的TENIS患者。
要点
- 10例mDTC患者共32个病灶,PSMA PET检出30个(93.75%),FDG PET/CT阳性23个(81.85%)。
- PSMA表达病灶中21/30(70%)位于骨骼。
- 2例TENIS患者PSMA PET均定位到病灶,与FDG PET一致。
核心结论
- 68Ga-PSMA-HBED-CC PET/CT是转移性分化型甲状腺癌患者潜在有用的影像手段,多数(70%)PSMA表达转移灶位于骨骼。
- PSMA PET/CT或有助于识别治疗选择有限(如TENIS)且可能从PSMA靶向放射性核素治疗中获益的患者。
主要发现
- 8例患者病灶摄碘,2例归为甲状腺球蛋白升高而碘闪烁显像阴性(TENIS)患者。
- 所有碘亲和转移性疾病患者均显示明显PSMA摄取。
- PSMA PET检出30/32个病灶(93.75%;SUVmax范围4.86-101.81,中位SUVmax 31.35),FDG PET/CT阳性23/32个病灶(81.85%)。
- 30个PSMA表达病灶中21个(70%)位于骨骼。
- 2例TENIS患者中PSMA PET各定位到一个病灶,与FDG PET扫描相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE OF THE REPORT: Prostate-specific membrane antigen (PSMA) overexpression is not restricted to prostate cancer, but it has also been demonstrated in gliomas, lung cancer, and in tumor neovasculature. Systematic studies exploring PSMA uptake in thyroid tumors are lacking. The aim of this pilot study was to assess PSMA expression in patients with metastatic differentiated thyroid cancer (mDTC). MATERIALS AND METHODS: Ten patients of mDTC harboring 32 lesions (5 men; age range, 38-65 years; mean age, 50 years) underwent prospective evaluation with radioiodine (I), F-FDG PET, and Ga-PSMA-HBED-CC PET scans as per the institution protocol. PSMA expression (SUVmax) was compared with F-FDG and I scan findings in all patients. RESULTS: Lesions were radioiodine avid in 8 patients, whereas 2 were classified as thyroglobulin elevation with negative iodide scintigraphy (TENIS) patients. All patients with iodine-avid metastatic disease showed substantial PSMA uptake. PSMA PET detected 30/32 total lesions (93.75%; SUVmax ranging from 4.86 to 101.81 with median SUVmax of 31.35), whereas FDG PET/CT was positive in 23/32 lesions (81.85%). Twenty-one (70%) of 30 lesions that showed PSMA expression were localized to the bones. PSMA localized a lesion in each of the 2 TENIS patients similar to FDG PET scan. CONCLUSIONS: Ga-PSMA-HBED-CC PET/CT is a potentially useful imaging modality in patients of mDTC with most (70%) of PSMA expressing metastasis being localized to the bones. PSMA PET/CT could be useful for identifying patients with limited therapeutic options (eg, TENIS) who might benefit from PSMA-targeted radionuclide therapy.
引用
- Verma P, Malhotra G, Agrawal R, et al. Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET/CT. Clin Nucl Med. 2018. PMID: 29894335. doi:10.1097/RLU.0000000000002161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。